Laboratory Characterisation of MK-2866
MK-2866 (Ostarine/Enobosarm) is a non-steroidal selective androgen receptor modulator recognised as one of the most extensively studied SARMs compounds. This Cartel Labz formulation delivers 15mg per capsule, enabling precise research applications investigating tissue-selective androgenic activity. Researchers at Stroid UK Shop can examine this aryl-propionamide compound’s selective modulation of androgen receptors across various tissue models.
Ostarine demonstrates remarkable selectivity in preclinical studies, showing preferential binding to androgen receptors in muscle and bone tissue whilst exhibiting reduced activity in reproductive organs. The compound’s molecular structure enables investigation of selective androgen receptor pathways, making it valuable for researchers studying muscle wasting conditions and bone metabolism. This ostarine preparation has undergone extensive clinical evaluation, with data from over 25 studies involving more than 1,700 subjects according to manufacturer documentation.
Research Applications and Molecular Mechanisms
Laboratory studies examine MK-2866’s unique mechanism as a partial androgen receptor agonist, investigating its tissue-selective properties through various research models. Scientists analyse how this compound modulates gene expression related to muscle protein synthesis whilst minimising androgenic effects in non-target tissues. The oral bioavailability confirmed in preclinical models makes this compound particularly suitable for extended research protocols examining sustained androgen receptor modulation. Researchers exploring broader SARMS mechanisms often investigate ostarine’s comparative selectivity profiles.
Current research investigates ostarine’s potential applications in cancer-related cachexia models, stress urinary incontinence pathways, and sarcopenia mechanisms. The compound’s ability to maintain anabolic activity whilst demonstrating reduced prostate enlargement in animal models provides valuable insights for androgen receptor research. Studies examine dosing protocols, pharmacokinetic parameters, and tissue distribution patterns to understand optimal research conditions. Comparative studies with peptide modulators help researchers understand different approaches to muscle and bone research applications.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Ostarine/Enobosarm |
| CAS Number | 841205-47-8 |
| Molecular Formula | C₁₉H₁₄F₃N₃O₃ |
| Molecular Weight | 389.33 g/mol |
| Dosage Form | 15mg capsules |
| Storage Conditions | Room temperature, dry environment |
| Stability | Stable under recommended storage |
| Solubility | DMSO, ethanol soluble |
Laboratory Compliance and Research Use
This product is manufactured strictly for in-vitro research applications and detailed laboratory studies of selective androgen receptor modulation mechanisms. Researchers must ensure appropriate laboratory safety protocols and proper waste disposal procedures when conducting studies with this compound. All research applications should be conducted within appropriate institutional frameworks with proper oversight and documentation. This product is not intended for human consumption, therapeutic applications, or any purpose outside controlled laboratory research environments.
